FinanceAYR Wellness Has No Estimate for Q1 2025 Interim Filings; Trading Remains on HoldThe cannabis company’s delay in filing its financial statements comes as its negotiations with creditors remain ongoing.AYR Wellness Inc.Posted by CBT StaffJune 27, 2025RecommendedAscend Wellness Reports $127M in Q2 Net RevenueTerrAscend Reports $65M in Q2 Revenue From Continuing OperationsVerano Reports $202M in Q2 RevenueCresco Labs Reports $164M in Q2 RevenueRelated StoriesAurora Cannabis Denies 2nd ‘False’ News Report of Acquisition of MedLeaf TherapeuticsVireo Growth Provides Corporate Update After Closing All Merger TransactionsAYR Fails to Complete Q1 2025 Interim Financial Filings; Cease-Trade Order Remains in EffectAYR Wellness Issued Cease Trade Order by Ontario Securities Commission